Advertisement
ADVANCED SEARCH

This Article Full Text Full Text (PDF) [Online Table] Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiavetta, J. A. Articles by Sher, G. Search for Related Content PubMed PubMed Citation Articles by Chiavetta, J. A. Articles by Sher, G. Related Collections HIV infection, AIDS Hematologic pathology (including blood transfusion)

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000

At the time of writing, from the National Epidemiology and Surveillance Department, Canadian Blood Services, Toronto, Ont. (Chiavetta, Newman, He, Driezen, Deeks, Hone, O'Brien); the Department of Public Health Sciences, University of Toronto, Toronto, Ont. (Escobar); and Canadian Blood Services, Ottawa, Ont. (Sher)

Correspondence to: Dr. Jo Anne Chiavetta, Epi-Stat Research Inc., 910–44 Charles St. W, Toronto ON M4Y 1R7; jchiavetta{at}sympatico.ca

Background: Since 1990, the Canadian Red Cross Society and Canadian Blood Services have been testing blood donors for hepatitis C virus (HCV) antibody and HCV nucleic acids and have supplemented HIV antibody testing with p24 antigen testing. We report trends in the incidence of blood-transmissible viral markers and estimates of the risk of undetected infection in donors over the last decade.

Methods: We extracted anonymous donor and blood-transmissible disease information from the Canadian Blood Services National Epidemiology Donor Database for 8.9 million donations from 2.1 million donors between June 1990 and December 2000. The risk of transfusion-transmitted infection (or "residual risk") refers to the chance that an infected donation escapes detection because of a laboratory test's window period (i.e., the time between infection and detection of the virus by that test). We determined the probability of residual contamination of a unit of blood after testing by using the incidence/window period model, which is based on the incidence of infection in repeat donors and the window period for each laboratory test. The viral markers evaluated in the study were HIV, HCV, hepatitis B virus (HBV) and human T-cell lymphotropic virus (HTLV).

Results: Except for HBV, the transmissible-disease rates of the other evaluated viruses decreased over the study period, with less of a decrease for HTLV. In 2000, the transmissible-disease–positive rate per 100 000 donations was 0.38 for HIV, 16.83 for HCV, 12.40 for HBV and 1.77 for HTLV. The residual risk of HIV, HCV and HTLV decreased over the study period; the residual risk of HBV fluctuated throughout the decade. The current residual risk per million donations is 0.10 for HIV, 0.35 for HCV, 13.88 for HBV and 0.95 for HTLV.

Interpretation: Except for HBV, the estimated risk of undetected infection (residual risk) has decreased over time. The rates of transmissible disease and the probability of undetected transmission of infection are at par with, if not lower than, those reported for other industrialized countries.

This article has been cited by other articles:

				P. Martin-Davila, J. Fortun, R. Lopez-Velez, F. Norman, M. Montes de Oca, P. Zamarron, M. I. Gonzalez, A. Moreno, T. Pumarola, G. Garrido, et al. Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation Clin. Microbiol. Rev., January 1, 2008; 21(1): 60 - 96. [Abstract] [Full Text] [PDF]

				M. Ando, Y. Takahashi, and N. Suzuki Open Heart Surgery for Small Children Without Homologous Blood Transfusion by Using Remote Pump Head System Ann. Thorac. Surg., November 1, 2004; 78(5): 1717 - 1722. [Abstract] [Full Text] [PDF]

				M. Germain, S. Gelinas, and G. Delage Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec Can. Med. Assoc. J., March 30, 2004; 170(7): 1077 - 1078. [Full Text] [PDF]

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-2003, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.